pulmonology

(redirected from Pulmonary diseases)
Also found in: Dictionary, Encyclopedia.
Related to Pulmonary diseases: COPD

pulmonology

(po͝ol′mə-nŏl′ə-jē, pŭl′-)
n.
The branch of medicine that deals with diseases of the respiratory system.

pul′mo·nol′o·gist n.

pulmonology

[poo͡l′mōnol′ə·jē]
Etymology: L, pulmo, lung
the science concerned with the anatomy, physiology, and pathology of the lungs.

pulmonology

The study of the lungs and respiratory function
References in periodicals archive ?
National Jewish Medical and Research Center is a nationally recognized research institute located in Denver, CO specializing in pulmonary disease.
A study using losartan in PAH secondary to chronic obstructive pulmonary disease was also in the acute setting and oral dosing with losartan (50 mg) produced a significant reduction in mean PAP and total pulmonary vascular resistance (8).
Even in patients without depression, pulmonary disease should be considered a red flag, she and her colleagues conclude in the July/August Psychosomatic Medicine.
BROVANA is indicated for the long-term, twice-daily (morning and evening) maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Food and Drug Administration (FDA) approved its New Drug Application (NDA) for BROVANA([TM]) (arformoterol tartrate) Inhalation Solution 15 mcg (micrograms) as a long-term, twice-daily (morning and evening), maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Hollis-Eden also is profiling optimized second-generation compounds for potential clinical development in a broad spectrum of therapeutic categories including hematology, metabolic disorders, autoimmune disorders, pulmonary diseases, oncology and infectious diseases.
PUR1900 is the lead product candidate in the Company's proprietary pipeline that is strategically focused on developing innovative, first-in-class inhaled therapies for rare pulmonary diseases.
Professor of Medicine and Division Chief of Pulmonary Diseases and Critical Care Medicine, University of North Carolina, School of Medicine, Department of Medicine at Chapel Hill.
Food and Drug Administration for clearance of the company's Vas Zeppelin (TM) Smart Catheter (TM) for the treatment of chronic pulmonary diseases and lung cancer.
The ability to produce functional, three-dimensional lung tissue in the laboratory would provide a valuable source of engineered replacement tissue to treat a variety of pediatric pulmonary diseases.
Chronic Obstructive Pulmonary Diseases (COPD) and lung cancer cause increasingly prominent public health disorders, creating major economic challenges for our societies and healthcare systems.
The observed effect of CRx-170 in such a short period of dosing, as measured by FEV1, the most clinically relevant endpoint and generally accepted measure of clinical activity, suggests that CRx-170 may have potential as a novel agent for the treatment of pulmonary diseases such as asthma and COPD," said Dr.